ESMO 2022 | Effects of the tumor microenvironment on therapeutic response
Kevin Litchfield
• 9 Sep 2022
Kevin Litchfield, PhD, University College London, London, UK, discusses how the tumor microenvironment affects therapeutic responses and explains how the balance between immunostimulatory and immunosuppressive cell types plays a role in this. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
